Increasing emphasis has been placed on the role of the serotonin 5-HT2A receptor in the pathogenesis of schizophrenia and affective disorders. In particular, the therapeutic effects of antipsychotic drugs have been suggested to be due to their actions at the 5-HT2A receptor that lead to changes in receptor density. However, the functional consequences of such receptor changes have not been fully examined. The innovative aspect of this proposal derives from: 1) our use of an animal model in which associative learning (a process that is abnormal in schizophrenia) is regulated by the 5-HT2A receptor, 2) our ability to detect changes in learning that result from alterations in the density of the 5-HT2A receptor in the adult brain, and 3) our preliminary evidence that the 5-HT2A receptor is constitutively active. We now propose to examine in detail how both the up- and down- regulation of the 5-HT2A receptor in limbic cortex, brain regions that are thought to be affected in schizophrenia, alters the rate of learning, the neuronal circuitry within those brain regions, the development of long-term potentiation (an in vitro model of learning), the constitutive activity of the receptor, and receptor mediated second messenger signaling. Learning is measured during classical trace conditioning of the rabbit's eye-blink response, a form of learning that is regulated by the 5-HT2A receptor, and is dependent on the integrity of limbic cortex (hippocampus and frontal cortex). It is important to note that eyeblink conditioning is also impaired in schizophrenia. Intracerebral injections of drugs will be used to identify the critical brain loci at which the 5-HT2A receptors regulate learning. Depletions of brain serotonin will be employed to determine the extent of constitutive activity at the 5-HT2A receptor as measured by basal and agonist stimulated second messenger signalling. The results of this research should provide novel therapeutic strategies in the treatment of schizophrenia. In addition, this research will provide a new perspective and new insights into the neurobiology of learning.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH016841-41
Application #
7534827
Study Section
Neurobiology of Motivated Behavior Study Section (NMB)
Program Officer
Osborn, Bettina D
Project Start
1988-09-01
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2010-11-30
Support Year
41
Fiscal Year
2009
Total Cost
$320,012
Indirect Cost
Name
Drexel University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
002604817
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Schindler, Emmanuelle A D; Harvey, John A; Aloyo, Vincent J (2013) Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex. Brain Res 1491:98-108
Schindler, Emmanuelle A D; Dave, Kuldip D; Smolock, Elaine M et al. (2012) Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Pharmacol Biochem Behav 101:69-76
Scarlota, Laura C; Harvey, John A; Aloyo, Vincent J (2011) The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B. Psychopharmacology (Berl) 213:393-401
Romano, Anthony G; Quinn, Jennifer L; Li, Luchuan et al. (2010) Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al. Psychopharmacology (Berl) 212:441-8
Oristaglio, Jeff; Romano, Anthony G; Harvey, John A (2009) Amphetamine influences conditioned response timing and laterality of anterior cingulate cortex activity during rabbit delay eyeblink conditioning. Neurobiol Learn Mem 92:1-18
Aloyo, V J; Berg, K A; Spampinato, U et al. (2009) Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors. Pharmacol Ther 121:160-73
Romano, A G; Du, W; Harvey, J A (1994) Methylenedioxyamphetamine: a selective effect on cortical content and turnover of 5-HT. Pharmacol Biochem Behav 49:599-607
Chen, J F; Aloyo, V J; Qin, Z H et al. (1994) Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum. Neurochem Int 25:355-66
Chen, J F; Aloyo, V J; Weiss, B (1993) Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54:669-80
Harvey, J A; Welsh, J P; Yeo, C H et al. (1993) Recoverable and nonrecoverable deficits in conditioned responses after cerebellar cortical lesions. J Neurosci 13:1624-35

Showing the most recent 10 out of 31 publications